Arctic Aurora LifeScience H

Performance History31/10/2024
Growth of 1,000 (EUR)
Arctic Aurora LifeScience H
Fund2.810.0-7.61.55.4
+/-Cat-----
+/-Idx-----
 
Key Stats
NAV
21/11/2024
 NOK 1808.08
Day Change 0.79%
Morningstar Category™ Other Equity
ISIN IE00BDHFW354
Fund Size (Mil)
31/10/2024
 NOK 2129.83
Share Class Size (Mil)
31/10/2024
 NOK 163.82
Max Initial Charge -
Ongoing Charge
29/12/2023
  1.16%
Investment Objective: Arctic Aurora LifeScience H
The investment objective is to achieve long-term capital appreciation through global equity investments within the pharmaceuticals, biotechnology and life science sectors. The team has more than 50 years of experience from the industry, and will utilize their know-how to pick the early winners in a fast developing life science and biotech space.
Returns
Trailing Returns (EUR)21/11/2024
YTD2.59
3 Years Annualised-0.99
5 Years Annualised3.73
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
Ulrica Bjerke
27/05/2016
Daniel Bolanowski
01/06/2021
Inception Date
30/06/2016
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
MSCI World/Pharma Bio&Life NR NOK-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingYes
OtherNot Specific
Portfolio Profile for  Arctic Aurora LifeScience H30/09/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks96.930.0096.93
Bonds0.000.000.00
Cash1.020.001.02
Other2.050.002.05
Top 5 Regions%
United States70.42
Europe - ex Euro13.18
United Kingdom7.10
Eurozone4.57
Japan3.98
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Eli Lilly and CoHealthcareHealthcare8.98
AstraZeneca PLCHealthcareHealthcare5.30
Novo Nordisk AS Class BHealthcareHealthcare4.84
Merck & Co IncHealthcareHealthcare3.38
Ultragenyx Pharmaceutical IncHealthcareHealthcare3.27
Arctic Aurora LifeScience H
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookie Settings        Disclosures